e-learning
resources
Vienna 2012
Sunday, 02.09.2012
COPD comorbidities I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prognostic value of the Charlson Comorbidity Index in patient with COPD
N. Karoli, A. Rebrov (Saratov, Russian Federation)
Source:
Annual Congress 2012 - COPD comorbidities I
Session:
COPD comorbidities I
Session type:
Thematic Poster Session
Number:
524
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Karoli, A. Rebrov (Saratov, Russian Federation). Prognostic value of the Charlson Comorbidity Index in patient with COPD. Eur Respir J 2012; 40: Suppl. 56, 524
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Effects of nintedanib in patients with IPF: subgroup analysis by Charlson Comorbidity Index (CCI)
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020
The prognostic value of the Charlson’s comorbidity index in patients with bacteremic pneumonia
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
Association between Frailty Index and BODE index with lung function and mortality in COPD
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020
Prognostic value of the pneumonia severity index (PSI), CURB-65 for young and elderly patients
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
Bronchiectasis Severity Index and FACED score correlation determinants
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Index of barthel and disability in elderly COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 516s
Year: 2002
Severity of bronchiectasis: FACED Score vs Bronchiectasis Severity Index
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Could age-adjusted Charlson comorbidity index predict outcomes in patients submitted to noninvasive ventilation?
Source: International Congress 2017 – Noninvasive ventilation for acute respiratory failure
Year: 2017
Comorbidity level in asthma patients
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Higher BODE Index in COPD patients correlated with higher number of comorbidities
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Clinical COPD questionnaire (CCQ) score and mortality
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity?
Source: International Congress 2014 – Clinical presentations
Year: 2014
Multidimensional system for assessment of COPD patients. Comparison with BODE index
Source: Eur Respir J 2005; 26: Suppl. 49, 442s
Year: 2005
Prognostic significance of Glasgow Prognostic Score in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
Hyaluronic acid is associated with survival time in stable COPD independently of exacerbation rate, BODE index and adjusted Charlson score
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
The PROGRESS Study - Operationalization of Disease Severity and Prediction ofOutcome using the SOFA Score
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
Symptom scoring in COPD patients
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008
Prognostic Assessment In Copd Subjects: BODE Index And The Health-Related Quality Of Life
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Comorbidity in patients with IHD - the prevalence of COPD
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
CURB65 versus PSI in assessing the severity of CAP of elderly patients
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept